Increasing peptide and oligonucleotide API concentration prior to isolation is often critical to improving manufacturing efficiency, maximizing asset…
The rising demands for therapeutic oligonucleotides requires scalable, efficient, and more sustainable manufacturing solutions. Stirred bed…
About the webinar Oligonucleotides are emerging new therapeutic entities, and reliable selective analytical methods to determine their…
About the webinar As demand for peptide-based APIs grows, selecting the most efficient and cost-effective manufacturing route is critical.…
Linear synthesis by continuous-flow SPOS is the current state-of-the-art technology to manufacture oligonucleotide APIs. A very promising alternative,…
Recent years have seen drug recalls based on nitrosamine drug substance related impurities (NDSRIs), with medical agencies…
The expert panel discussion focused on evolving trends in the pharmaceutical industry, particularly the growing importance of…
Peptides can be utilized as critical raw materials for in vitro diagnostics (IVD) to measure the presence…
Developing peptide and oligonucleotide APIs demands a precise balance of efficiency, quality and compliance. To meet the…
The oligotherapeutics market has expanded in size, disease indications and exploratory molecules in recent years, As oligo…